VatajaYonivyapada (gynecological condition): Scope in Ayurveda
DOI:
https://doi.org/10.46947/joaasr442022450Keywords:
Vatajayonivyapada, gynecologicaldisorders,RasnadiksheerapakaAbstract
Introduction: Vatajayonivyapada having signs and symptoms such as pain along with abnormalities in menstrual bleeding matches with many of the gynaecologicaldisorders in women of reproductive age group. It hampers their day-to-day chores and disturbing their interpersonal relationship and most importantly compromises quality of life. Therefore, an instant relief of symptoms is required along with an overall improvement in the general condition of those women.In such conditions, a better alterative non-hormonal Ayurvedic management is planned. Ksheerapaka(medicated milk preparations) of Rasna, Gokshuraand Vasa having vedanahara (analgesic effect) is used in the study. Objective: In this research work our objective was to evaluate the therapeutic efficacy of oral RasnadiKsheerapaka in Vatajayonivyapada. Materials and method: Total 30 patients within 20-40 years of ageirrespective of the marital status having classical symptoms of Vatajayonivyapada have been selected randomly from Prasuti Tantra OPD, S.S. Hospital, BHU, Varanasi. After detailed history, complete examination and investigations patients selected for the study on the basis of selection criteria.Patientswere treatedwith Rasnadiksheerapaka50ml orally once in a day for total duration of 45 days. Study was assessed after completion of follow-up period. Result: Among the 28 cases, 5 patients became cured and 6 remained without any improvement and all the remaining 17 patients have got mild to marked improvement in the signs and symptoms. Conclusion: It is concluded that Rasnadiksheerapakahas got the therapeutic efficacy in the Vatajayonivyapadamanagement. Also helps in improving the overall health status and quality of life in such women.
Metrics
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.